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Background Patients with renal insufficiency experience worse prognosis
after STEMI. 
Aim of the study to compare primary PCI (PPCI) and thrombolysis results
as well as in-hospital mortality after successful reperfusion between patients
with or without renal dysfunction (RD).
Methods From January 1995 to October 2014, 1588 patients admitted for
STEMI were enrolled in our registry. Two reperfusion groups were identified:
PPCI (315 patients) and thrombolysis (379 patients). We compared the group
of RD patients (RD+) and normal renal function patients (RD). Our main end-
points were: (1) The success of reperfusion and (2) the in-hospital mortality.
Results Ninety patients (13%) had RD, 50% of which underwent PPCI,
and 50% received thrombolytics. In the PPCI group, although TIMI flow was
similar before angioplasty (p=0.82), TIMI III flow restoration was signifi-
cantly lower in the RD+ group (78.6% vs 91.8%, p=0.013). 
Suboptimal result was also higher in the RD+ group (13.6% vs 2.7%,
p<0.001), but ST regression after TIMI III achievement was similar in the
2 groups (p=0.43) reflecting probably no microvascular damage. 
In the thrombolysis group, successful reperfusion was also significantly lower
when RD exists (58% vs 74%, p=0.03), but RD was not an independent predictor
of thrombolysis failure. RD was an independent mortality predictor either after
PPCI or thrombolysis (respectively p=0.014, OR=4.39 and p=0.006, OR=4.93).
After successful reperfusion, in-hospital mortality was higher among RD+
patients in the PPCI group (33.3% vs 4.3%, p<0.001), whereas it was similar
after successful thrombolysis (p=0.42).
In-hospital mortality was higher in RD+ patients when mechanically reper-
fused (40% vs 18.2%, p=0.024), whereas no significant difference was found
among RD- patients (p=0.75). 
Conclusion RD reduces PPCI success. 
Although RD was an independent mortality predictor regardless of the reper-
fusion strategy, prognosis was worse in RD group only after successful PPCI.
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Introduction and objectives In moderate or high risk non-ST segment ele-
vation acute coronary syndrome, clinical practice guidelines recommend a
coronary angiography with intent to revascularize. However, evidence to sup-
port this recommendation in very elderly patients is poor.
Methods All patients over 85 years old (military hospitals of Algeria)
admitted between 2006 and 2014 with a diagnosis of non-ST segment eleva-
tion acute coronary syndrome were retrospectively included. Using a propen-
sity score, patients undergoing the interventional approach and those
undergoing conservative management were matched and compared for sur-
vival and survival without ischemic events.
Results We included 167 consecutive patients with a mean age of 88 years
(range: 85 to 101). Those in the interventional approach group (n=67) were
younger, with a higher proportion of males and less comorbidity, less cogni-
tive impairment and lower troponin I levels compared with patients in the con-
servative management group (n=100). 
We matched 60patients from the interventional approach group and 60
from the conservative management group using propensity score. In the
matched patients, the interventional approach group exhibited better survival
(log rank 4.24; P=0.039) and better survival free of ischemic events (log rank
8.63; P=0.003) at the 3-year follow-up. In the whole population, adjusted for
propensity score quintiles, the interventional approach group had lower mor-
tality (hazard ratio 0.52; 95% confidence interval: 0.32-0.85) and a better sur-
vival free of ischemic events (hazard ratio 0.48; 95% confidence interval:
0.32-0.74).
Conclusions Nearly all the very elderly patients admitted with non-ST seg-
ment elevation acute coronary syndrome were of moderate or high risk. In
these patients, the interventional approach was associated with overall better
survival and better survival free of ischemic events.
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Aims Fractional flow reserve (FFR) invasively assesses the ischemic poten-
tial of coronary stenosis.FFR value of 0.75 has been referred to the ischemic
FFR threshold validated against non-invasive functional testing; while an FFR
value of 0.80 has guided clinical decision making in multicenter clinical trials.
Revascularization in case of FFR values in the gray zone between 0.75-0.80
is still debatable. We investigated the clinical outcome of patients with an iso-
lated stenosis and FFR value in the gray zone. 
Methods From 1997 to 2013, we retrospectively included all patients with
single segment disease at coronary angiography and FFR between 0.70-0.85.
We defined the following FFR groups: a) 0.70-0.75; b) 0.76-0.80 (gray zone);
Abstratct 0456 – Table: Reperfusion rates, types, timing and adjunctive medications among the age groups
Age groups 
<65 years
n=3476
65-74 years
n=1238
75-84 years
n=1147
85 years
n=308 P-value
No reperfusion, n (%) 3.8 5.6 8.0 13.6 <0.001
Fibrinolysis, n (%) 1853 (53.3) 593 (47.9) 449 (39.2) 87 (28.3) <0.001
Primary PCI, n (%) 1492 (42.9) 576 (46.5) 606 (52.8) 179 (58.1) <0.001
Delay (first medical contact to PPCI), median (IQR), min 80 (58-123) 85 (60-125) 85 (64-130) 84 (60-124) 0.1
Bivalirudin*, n/N (%) 81/1197 (6.8) 30/429 (7.0) 48/373 (12.9) 28/121(23.1) <0.001
GPI*, n/N (%) 1375/2695 (51.0) 493/963 (51.2) 435/879 (49.5) 85/222 (38.3) 0.003
* Calculated among patients undergoing a coronarography. Bivalirudin has been used since 2008.
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